alexa Editor - Qing H. Meng | University of Texas MD Anderson Cancer C | 4306
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Share This Page

Qing H. Meng

Qing H. Meng
Qing H. Meng
Department of Laboratory Medicine
University of Texas MD Anderson Cancer Center
USA
Tel: 713-792-6320
Fax: 713-792-4793
University of Texas MD Anderson Cancer Center

Biography

Qing-He Meng received his medical education and had practiced as a physician for 8 years in China. He obtained his PhD in Clinical Chemistry from the University of Helsinki, Finland, in 1999. Following postdoctoral training in Clinical Chemistry at McMaster University, he assumed the position of Clinical Chemist/Assistant Professor at Royal University Hospital, University of Saskatchewan, Canada in 2003. He then moved to the Hospital for Sick Children, the University of Toronto and took the position as a Clinical Chemist and Assistant Professor in 2006. Currently he is Associate Director of Clinical Chemistry at Royal University Hospital and Clinical Professor at the University of Saskatchewan, Canada. Qing is a Diplomate of the American Board of Clinical Chemistry (ABCC) and Fellows of NACB (FACB) and the Canadian Academy of Clinical Biochemistry (FCACB).

Research Interest

Qing H. Meng  research interests cover different aspects from basic study to translational and clinical investigations. The major areas of his research include 1). Diabetes and atherosclerosis: lipid metabolism, dislipidemia, atherosclerosis, nutrition, insulin resistance, diabetes and diabetic complications. 2). Clinical investigation on cardiovascular risk factors and risk markers: hyperlipidemia, hyperhomocysteinemia, hyperglycemia, and coronary artery disease; the role of cardiac biochemical markers in the diagnosis and prediction of ischemic myocardial injury. 3). Laboratory investigation: instrument evaluation, method development and validation, laboratory error and test interference investigation.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Mass Spectrometry Applications in Clinical Diagnostics

Qing H. Meng
Editorial: J Clinic Experiment Pathol 2013, S6: e001
DOI: 10.4172/2161-0681.S6-e001
Top